GSRCX
Price
$12.27
Change
-$0.08 (-0.65%)
Updated
Oct 7 closing price
Net Assets
432.18M
VIVAX
Price
$73.01
Change
-$0.09 (-0.12%)
Updated
Oct 7 closing price
Net Assets
207.8B
Interact to see
Advertisement

GSRCX vs VIVAX

Header iconGSRCX vs VIVAX Comparison
Open Charts GSRCX vs VIVAXBanner chart's image
Goldman Sachs Rising Dividend Gr C
Price$12.27
Change-$0.08 (-0.65%)
VolumeN/A
Net Assets432.18M
Vanguard Value Index I
Price$73.01
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets207.8B
GSRCX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
GSRCX vs. VIVAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. GSRCX (432M). VIVAX pays higher dividends than GSRCX: VIVAX (1.97) vs GSRCX (0.62). GSRCX was incepted earlier than VIVAX: GSRCX (21 years) vs VIVAX (33 years). GSRCX (2.02) is less costly to investors than VIVAX (0.17). GSRCX is a more actively managed with annual turnover of: 42.00 vs. VIVAX (9.00). GSRCX has a lower initial minimum investment than VIVAX: GSRCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.19 vs. GSRCX (-5.48). VIVAX return over 5 years is better than : 73.42 vs. GSRCX (26.00).
GSRCXVIVAXGSRCX / VIVAX
Total Expense Ratio1.760.171,035%
Annual Report Gross Expense Ratio2.020.171,188%
Fund Existence21 years33 years-
Gain YTD7.78910.73873%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets432M208B0%
Annual Yield % from dividends0.621.9732%
Returns for 1 year-5.488.19-67%
Returns for 3 years14.8349.0830%
Returns for 5 years26.0073.4235%
Returns for 10 years-33.47132.94-25%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.550.19
+5.65%
Psyence Biomedical Ltd
OKYO2.03-0.01
-0.49%
OKYO Pharma Limited
RVTY91.19-2.19
-2.35%
Revvity
SEI44.05-2.70
-5.78%
Solaris Energy Infrastructure Inc
CBLL11.80-0.77
-6.13%
CERIBELL INC